A Multicenter, Prospective, Randomized Controlled Study Comparing the Efficacy and Safety of CLAG(Cladribine, Cytarabine and G-CSF) Combined With Venetoclax and CLAG in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs Cladribine (Primary) ; Cytarabine (Primary) ; Filgrastim (Primary) ; Venetoclax (Primary) ; Granulocyte colony-stimulating factors
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 16 Jan 2025 New trial record